Melanoma incidence trends

Dermatologic Clinics

Volumn 20, Issue 4, 2002, Pages 589-595

  Bevona, Caroline ^a   Sober, Arthur J ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER SUSCEPTIBILITY; HUMAN; MELANOMA; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; FEMALE; FORECASTING; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; PREVALENCE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; SEX DISTRIBUTION; SKIN NEOPLASMS; SURVIVAL ANALYSIS; WORLD HEALTH ORGANIZATION;

EID: 0036787375     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(02)00037-2     Document Type: Review

References (61)

1. Titus-Ernstoff L. An overview of the epidemiology of cutaneous melanoma. Clin Plast Surg 2000;27:305-16.
2. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 1994;20:219-40.
3. MacKie RM. Incidence, risk factors and prevention of melanoma. Eur J Cancer 1998;34(suppl 3):S3-6.
4. Brozena SJ, Fenske NA, Perez IR. Epidemiology of malignant melanoma, worldwide incidence, and etiologic factors [review]. Semin Surg Oncol 1993;9: 165-7.
5. Crombie IK. Racial differences in melanoma incidence. Br J Cancer 1979;40:185-93.
6. Crombie IK. Variation of melanoma incidence with latitude in North America and Europe. Br J Cancer 1979;40:774-81.
7. Holman CD, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984;73:75-82.
8. Lancaster HO, Nelson J. Sunlight as a cause of melanoma: a clinical survey. Med J Aust 1957;1:452-6.
9. Weinstock MA. Issues in the epidemiology of melanoma. Hematol Oncol Clin North Am 1998;12:681-98.
10. Weinstock MA. Overview of ultraviolet radiation and cancer: what is the link? How are we doing? Environ Health Perspect 1995;103(suppl 8):251-4.
11. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents, vol. 7. Lyon: International Agency for Research on Cancer, 1ARC Scientific Publications No. 143; 1997.
12. Berwick M. Epidemiology: current trends, risk factors, and environmental concerns. In: Balch CM, Houghton AN, Sober AJ, et al, editors. Cutaneous melanoma. edition 3. St. Louis, MO: Quality Medical Pub.; 1998. p. 551-71.
13. Builliard JL, Cox B, Elwood J. Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand. Cancer Causes Control 1994;5:234-40.
14. Sober A, Lew RA Koh H, et al. Melanoma/skin cancer update 1991. Dermatol Clin 1991;9:617-817.
15. Fitzpatrick TB. Enigma of the pathogenesis of primary melanoma: changing incidence and mortality in Japan and the United States. J Invest Dermatol 1989; 92(suppl 5):234S-5S.
16. Australian Institute of Health and Welfare (AIHW), Australasian Association of Cancer Registries (AARC). Cancer in Australia 1997: incidence and mortality data for 1997 and selected data for 1998 and 1999. AIHW cat. no. CAN 10. Canberra: AIHW (Cancer Series no. 15);2000.
17. Boyle P, Maisonneuve P, Dore JF. Epidemiology of malignant melanoma. Br Med Bull 1995;51:523-47.
18. Elwood JM. Recent developments in melanoma epidemiology, 1993. Melanoma Res 1993;3:149-56.
19. Kricker A, Armstrong B. International trends in skin cancer, September, 1996. Available at: http:// home.vicnet.net.au/-menzies/krick.htm. Accessed October 25, 2001.
20. MacKie RM. The epidemiology of melanoma in the West. Melanoma Res 1997;7(suppl 1):S1.
21. Marks R. Two decades of the public health approach to skin cancer control in Australia: why, how and where are we now? Australas J Dermatol 1999;40:1-5.
22. Severi G, Giles GG, Robertson C, et al. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 2000;82:1887-91.
23. Bulliard JL, Cox B. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. Int J Epidemiol 2000;29:416-23.
24. Bulliard JL, Cox B, Semenciw R. Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969-93. Cancer Causes Control 1999;10: 407-16.
25. Giles GG, Thursfield V. Trends in skin cancer in Australia, September, 1996. Available at: http://home. vicnet.et.au/-menzies/giles.htm. Accessed October 25, 2001.
26. Hursthouse MW. Melanoma incidence and trends in the Nelson-Marlborough area of New Zealand. N Z Med J 1992;105:424-5.
27. MacKie RM, Hole D, Hunter JA, et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. BMJ 1997;315:1117-21.
28. Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer 2001;92: 457-62.
29. Marks R. Epidemiology of melanoma. Clin Exp Dermatol 2000;25:459-63.
30. Czarnecki D, Meehan CJ. Is the incidence of malignant melanoma decreasing in young Australians? J Am Acad Dermatol 2000;42:672-4.
31. New Zealand Health Information Services. Cancer: registrations and deaths. Wellington: Ministry of Health; 1997.
32. Jones WO, Harman CR, Ng AKT, et al. Incidence of malignant melanoma in Auckland, New Zealand: highest rates in the world. World J Surg 1999;23:732-35.
33. Gaudette LA, Gao RN. Changing trends in melanoma incidence and mortality. Health Rep 1998;10:29-41.
34. Giles GG, Armstrong BK, Burton RC, et al. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ 1996;312:1121-5.
35. Hall HI, Miller DR, Rogers JD, et al. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 1999;40:35-42.
36. Swerdlow AJ. International trends in cutaneous melanoma. Ann N Y Acad Sci 1990;609:235-51.
37. Yamamoto A. The epidemiology of melanoma in the East. Melanoma Res 1997;7(suppl 1):S1-2.
38. Boisseau-Garsaud AM, Garsaud P, Ossondo M, et al. Acral melanoma in the French West Indies (Martinique) [letter]. Arch Dermatol 1998;134:112-3.
39. Kato T, Suetake T, Sugiyama Y, et al. Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol 1996;134:383-7.
40. Crowley NJ, Dodge R, Vollmer RT, et al. Malignant melanoma in black Americans: a trend toward improved survival. Arch Surg 1991;126:1359-65.
41. Kato T, Suetake T, Tabata N, et al. Epidemiology and prognosis of plantar melanoma in 62 Japanese patients over a 28-year period. Int J Dermatol 1999;38:515-19.
42. Dennis LK. Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 Surveillance, Epidemiology, and End Results program registry. Arch Dermatol 1999;135:275-80.
43. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000; 88:2398-424.
44. Howe HL, Wingo PA, Thun MJ, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001;93:824-42.
45. Ries LAG, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1973-1998. Bethesda, MD: National Cancer Institute; 1998. Also available at: http://seer.-cancer.gov/Publications/CSR1973_1998. Accessed October 25, 2001.
46. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
47. Polednak AP. Trends in cancer incidence in Connecticut, 1935-1991. Cancer 1994;74:2863-72.
48. Polednak AP, Cancer incidence in Connecticut 1980-1996, October, 1999. Available at: http://www.state.c-t.us/dph/OPPE/pdfs/cancrpt2.pdf. Accessed October 25, 2001.
49. Polednak AP. Trends in cancer incidence in Connecticut. Conn Med 1997;61:211-8.
50. Roush GC, Schymura MJ, Holford TR. Patterns of invasive melanoma in the Connecticut Tumor Registry: is the long-term increase real? Cancer 1988;61: 2586-95.
51. Jemal A, Devesa SS, Hartge P, et al. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001;93:678-83.
52. La Vecchia C, Lucchini F, Negri E, et al. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer 1999;81: 62-6.
53. Roush GC, McKay L, Holford TR. A reversal in the long-term increase in deaths attributable to malignant melanoma. Cancer 1992;69:1714-20.
54. Scotto J, Pitcher H, Lee JA. Indications of future decreasing trends in skin-melanoma mortality among whites in the United States. Int J Cancer 1991;49: 490-7.
55. Mikkilineni R, Weinstock MA. Epidemiology. In: Sober AJ, Haluska FG, editors. Skin cancer. Hamilton, Ontario: BC Decker Inc; 2001. p. 1-15.
56. Dennis LK, White E, et al. Recent cohort trends in malignant melanoma by anatomic site in the United States. Cancer Causes Control 1993;4:93-100.
57. Burton RC, Armstrong BK. Current melanoma epidemic: a nonmetastasizing form of melanoma? [review]. World J Surg 1995;19:330-3.
58. Rees JL. The melanoma epidemic: reality and artefact. BMJ 1996;312:137-8.
59. Swerlick RA, Chen S. The melanoma epidemic: is increased surveillance the solution or the problem? Arch Dermatol 1996;132:881-4.
60. Rigel DS. Malignant melanoma: incidence issues and their effect on diagnosis and treatment in the 1990s. Mayo Clin Proc 1997;72:367-71.
61. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996; 34(5 pt 1):839-47.